Chlorthalidone: Don't call it "thiazide-Like" anymore

Hypertension

Volumn 56, Issue 3, 2010, Pages 335-337

  Kurtz, Theodore W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMLODIPINE; BENZOTHIAZEPINE DERIVATIVE; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; CHLORTALIDONE; DILTIAZEM; DIURETIC AGENT; ETHOXZOLAMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; NITRIC OXIDE; THIAZIDE DIURETIC AGENT;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; DIURETIC THERAPY; DRUG CLASSIFICATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HYPERTENSION; NOTE; PRIORITY JOURNAL;

CHLORTHALIDONE; DIURETICS; THIAZIDES;

EID: 77955983545     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.156166     Document Type: Note

References (16)

1. Elliott WJ, Grimm RH Jr. Using diuretics in practice: one opinion. J Clin Hypertens (Greenwich). 2008;10:856-862.
2. Ernst ME, Carter BL, Basile JN. All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective. J Clin Hypertens (Greenwich). 2009;11:5-10.
3. Kaplan NM. The choice of thiazide diuretics: why chlorthalidone may replace hydrochlorothiazide. Hypertension. 2009;54:951-953.
4. Sica DA. Chlorthalidone: a renaissance in use? Expert Opin Pharma-cother. 2009;10:2037-2039.
5. Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension. 2010;56:463-470.
6. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Muller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, Van Rooijen N, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D, Titze J. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009;15:545-552.
7. Bujak M, Frangogiannis NG. The role of TGF-/3 signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007;74:184-195.
8. Supuran CT. Carbonic anhydrases: an overview. Curr Pharm Des. 2008; 14:603-614.
9. Cotev S, Lee J, Severinghaus JW. The effects of acetazolamide on cerebral blood flow and cerebral tissue PO2. Anesthesiology. 1968;29: 471-477.
10. Siffert W, Fox G, Gros G. The effect of carbonic anhydrase inhibition on the velocity of thrombin-stimulated platelet aggregation under physiological conditions. Biochem Biophys Res Commun. 1984;121:266-270.
11. Temperini C, Cecchi A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: sulfonamide diuretics revisited-old leads for new applications? Org Biomol Chem. 2008;6:2499-2506.
12. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008;7:168-181.
13. Berg JT, Ramanathan S, Gabrielli MG, Swenson ER. Carbonic anhydrase in mammalian vascular smooth muscle. J Histochem Cytochem. 2004;52: 1101-1106.
14. Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure? J Renin Angiotensin Aldosterone Syst. 2004;5:155-160.
15. Aamand R, Dalsgaard T, Jensen FB, Simonsen U, Roepstorff A, Fago A. Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am J Physiol Heart Circ Physiol. 2009;297:H2068-H2074.
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, for the Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, and National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252. (Pubitemid 37553153)